Media Room

 

 

Latest News Releases
Nov 14, 2016

Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its corporate presentation at the Jefferies 2016 London Healthcare Conference to be held at the Waldorf...

Nov 9, 2016

Nektar Therapeutics (Nasdaq: NKTR) today announced that new Phase 1 clinical data for Nektar's lead immuno-oncology agent, NKTR-214, were presented at the SITC 2016 Annual Meeting. NKTR-214 is an...

Nov 3, 2016

Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2016. Cash and investments in marketable securities at September 30, 2016 were...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.
Media@purecommunications...

More »

Follow Us on LinkedIn
Follow Us on Twitter


print email
 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide